15 Biggest Mid-Day Losers For Tuesday
- Cleveland BioLabs, Inc. (NASDAQ: CBLI) shares tumbled 17.3 percent to $3.97 after surging 194.48 percent on Monday.
- Barracuda Networks Inc (NYSE: CUDA) shares declined 16.3 percent to $19.60. Barracuda posted upbeat earnings for its fourth quarter.
- Adeptus Health Inc (NYSE: ADPT) shares dropped 16.4 percent to $1.68.
- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) shares tumbled 15.5 percent to $1.25. Arena Pharmaceuticals priced its 60 million share offering at $1.15 per share.
- Inpixon (NASDAQ: INPX) shares dipped 14 percent to $2.84. Inpixon posted a Q4 GAAP net loss of $7.51 per share and disclosed that the FBI has renewed contract with Inpixon Federal.
- Wins Finance Holdings Inc (NASDAQ: WINS) shares fell 12 percent to $60.00.
- Cardinal Health Inc (NYSE: CAH) shares dropped 11.2 percent to $72.69. Cardinal Health announced plans to acquire patient portfolio from Medtronic for $6.1 billion. The company expects FY17adjusted earnings outlook at the bottom of its previous guidance range.
- OCI Partners LP (NYSE: OCIP) fell 9.9 percent to $7.75. Citigroup downgraded OCI Partners from Neutral to Sell.
- AirMedia Group Inc (ADR) (NASDAQ: AMCN) shares declined 9.5 percent to $2.81.
- Skypeople Fruit Juice Inc (NASDAQ: SPU) shares dropped 7.9 percent to $2.57. SkyPeople Fruit Juice reported a FY16 net loss of $5.5 million on sales of $34.4 million.
- Goldman Sachs Group Inc (NYSE: GS) shares declined 7.9 percent to $217.54 after the bank reported downbeat earnings for its first quarter.
- Kate Spade & Co (NYSE: KATE) shares dropped 7.2 percent to $18.01. Kate Spade reported Q1 GAAP earnings of $0.01 per share on revenue of $271 million.
- Wi-Lan Inc (USA) (NASDAQ: WILN) shares fell 6.1 percent to $1.87. WiLAN reported corporate developments and new growth strategy. The company also announced plans to buy International Road Dynamics for $3.17 per share in cash.
- Oncomed Pharmaceuticals Inc (NASDAQ: OMED) shares dropped 4.2 percent to $3.84. Cantor Fitzgerald downgraded Oncomed Pharmaceuticals from Buy to Neutral.
- Harley-Davidson Inc (NYSE: HOG) declined 3 percent to $57.59. Harley-Davidson posted upbeat quarterly earnings, but kept its guidance unchanged for 2017.
Posted-In: Mid-Day LosersNews Movers & Shakers Intraday Update Markets Analyst Ratings
© 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
